Carbamic Acid

Carbamic Acid

SCHEMBL570938

NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 1.00
LMNA P02545 5/20 0.62
ALDH1A1 P00352 4/20 0.62
TDP1 Q9NUW8 4/20 0.62
OR51E2 Q9H255 2/20 0.62
LDHA P00338 3/20 0.60
LDHB P07195 1/20 0.60
BLM P54132 5/20 0.50
PMP22 Q01453 4/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
ALOX15 P16050 2/20 0.50
CA1 P00915 1/20 0.50
CYP3A4 P08684 4/20 0.42
TSHR P16473 4/20 0.42
HSD17B10 Q99714 3/20 0.42
NFKB1 P19838 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42
THPO P40225 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL2 1.00
Carbamic Acid SCHEMBL4456232 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL30787477 1.00
Carbamic Acid SCHEMBL5048206 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL8512703 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL75781 1.00
Carbamic Acid SCHEMBL630836 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL2564971 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL4466151 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL27692345 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117800849-A Methyl cyclohexanediamine derivative and preparation method and application thereof 本源精化环保科技有限公司 2024-04-02 CN claimed
EP-3834017-B1 HIGH WATER CONTENT OPHTHALMIC DEVICES BAUSCH & LOMB (US) 2023-05-10 EP claimed
WO-2009091350-A1 POLYCARBAMIDES, POLYCARBAMATES, AND POLYCARBAMIDE-FORMALDEHYDE AND POLYCARBAMATE-FORMALDEHYDE CONDENSATION RESINS MISSISSIPPI STATE UNIVERSITY (US) 2009-07-23 WO claimed
CN-117800849-A Methyl cyclohexanediamine derivative and preparation method and application thereof 本源精化环保科技有限公司 2024-04-02 CN disclosed
CN-113507941-A Bioactive molecular cluster 萨普雷米科技有限公司 2021-10-15 CN disclosed
CN-113474009-A Improved antibody-oligonucleotide conjugates 萨普雷米科技有限公司 2021-10-01 CN disclosed
CN-113474010-A Saponins conjugated with epitope-binding proteins 萨普雷米科技有限公司 2021-10-01 CN disclosed
CN-113453722-A Improved cell-targeted binding molecules 萨普雷米科技有限公司 2021-09-28 CN disclosed
EP-2718261-A2 COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING SIRNA ACTIVITY Nitto Denko Corporation (JP) 2014-04-16 EP disclosed
US-8637492-B2 Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitates delivery into cells in vivo GENE TOOLS, LLC (US) 2014-01-28 US disclosed
US-8557182-B2 Site selectively tagged and templated molecularly imprinted polymers for sensor applications THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2013-10-15 US disclosed
WO-2004011566-A1 POLYESTER RESIN WITH CARBAMATE FUNCTIONALITY, A METHOD OF PREPARING THE RESIN, AND A COATING COMPOSITION UTILIZING THE RESIN BASF CORPORATION, PLEASE SEE GENERAL APPOINTMENT OF REPRESENTATIVE, ALLMAN, THOMAS Y., SENIOR VICE PRESIDENT, GENERAL COUNSEL (US) 2004-02-05 WO disclosed
WO-2004011565-A1 RHEOLOGY CONTROL AGENT, A METHOD OF PREPARING THE AGENT, AND A COATING COMPOSITION UTILIZING THE AGENT BASF CORPORATION, PLEASE SEE GENERAL APPOINTMENT OF REPRESENTATIVE, ALLMAN, THOMAS Y., SENIOR VICE PRESIDENT, GENERAL COUNSEL (US) 2004-02-05 WO disclosed
WO-2003089522-A1 POLYMERIC PIGMENT DISPERSANT UTILIZED AS A GRIND RESIN FOR PIGMENTS IN SOLVENTBORNE PIGMENT DISPERSIONS AND METHOD OF PREPARING THE SAME BASF CORPORATION, PLEASE SEE GENERAL APPOINTMENT OF REPRESENTATIVE, ALLMAN, THOMAS Y., SENIOR VICE PRESIDENT, GENERAL COUNSEL (US) 2003-10-30 WO disclosed
US-20030050432-A1 Polyester resin with carbamate functionality, a method of preparing the resin, and a coating composition utilizing the resin BASF CORPORATION 2003-03-13 US disclosed
US-20030009052-A1 Rheology control agent, a method of preparing the agent, and a coating composition utilizing the agent BASF CORPORATION 2003-01-09 US disclosed
US-20020156230-A1 Polymeric pigment dispersant utilized as a grind resin for pigments in solventborne pigment dispersions and method of preparing the same BASF CORPORATION 2002-10-24 US disclosed
EP-0117225-B1 N-(POLYALKYLPIPERIDINYL)-CARBAMATES OF POLYOLS CIBA-GEIGY AG (CH) 1991-11-13 EP disclosed
EP-0117225-A2 N-(Polyalkylpiperidinyl)-carbamates of polyols CIBA-GEIGY AG (CH) 1984-08-29 EP disclosed
US-4156784-A FROM UREA AND ALCOHOLS IN PRESENCE OF CATIONIC EXCHANGE RESINS CONTAINING NICKEL BASF AKTIENGESELLSCHAFT (DE) 1979-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009052-A1 Rheology control agent, a method of preparing the agent, and a coating composition utilizing the agent RFC5, CDC45, RHEB ACHE 83/4885LMNA 2374/4885ALDH1A1 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.